Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02714205 · ClinicalTrials.gov registry record · Phase 2
Flushing Reduction Associated With Nitrates
A Phase 2 study of Menopausal Hot Flashes, sponsored by Alison Huang, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 141
- Enrollment target
- 2
- Study locations
NCT02714205 is a Phase 2 study of Menopausal Hot Flashes that has completed, run by Alison Huang, MD. The registered enrollment target is 141 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02714205, a Phase 2 study of Menopausal Hot Flashes, has completed, sponsored by Alison Huang, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 141 participants
- Enrollment target
- 2
- Study locations
Study Summary
A randomized, double-blinded, placebo-controlled trial of uninterrupted transdermal nitrate therapy in 140 peri- or postmenopausal women who have frequent hot flashes. Women will be randomly assigned to uninterrupted use of transdermal nitrate therapy (participant directed dose-escalation of 0.2 to 0.6 mg/hr) or identical-appearing placebo patches for 12 weeks.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG transdermal nitroglycerin
Study Locations (2)
California
- University of California, San Francisco - Oakland
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2022-04-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02714205
The ClinicalTrials.gov registry entry for NCT02714205 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alison Huang, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menopausal Hot Flashes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02714205 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02714205 about?
NCT02714205 is a clinical study titled "Flushing Reduction Associated With Nitrates". A randomized, double-blinded, placebo-controlled trial of uninterrupted transdermal nitrate therapy in 140 peri- or postmenopausal women who have frequent hot flashes. Women will be randomly assigned to uninterrupted use of transdermal nitrate therapy (participant directed dose-escalation of 0.2 to ...
What is the current status of trial NCT02714205?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 141 participants. The study started on 2017-04-24. Estimated completion is 2022-04-05.
What conditions does trial NCT02714205 study?
This clinical trial studies the following conditions: Menopausal Hot Flashes.
What interventions are being tested in trial NCT02714205?
The interventions under investigation include: Placebo (DRUG), transdermal nitroglycerin (DRUG).
Who is sponsoring clinical trial NCT02714205?
This trial is sponsored by Alison Huang, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02714205 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.